<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/423145</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Epidemiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estimating the current burden of Chagas disease in Mexico: a systematic review of epidemiological surveys from 2006 to 2017</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Arnal</surname><given-names>Audrey</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Waleckx</surname><given-names>Etienne</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Herrera</surname><given-names>Claudia</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9376-0209</contrib-id>
<name><surname>Dumonteil</surname><given-names>Eric</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Centro de Investigaciones Regionales Dr Hideyo Noguchi</institution>, Universidad Aut&#x00F3;noma de Yucat&#x00E1;n, calle 96 s/n x av. Jacinto Canek y calle 47, Col. Paseo de las Fuentes, CP 97225, M&#x00E9;rida, Yucat&#x00E1;n, <country>M&#x00E9;xico</country></aff>
<aff id="a2"><label>2</label><institution>Department of Tropical Medicine</institution>, School of Public Health and Tropical Medicine, and Vector-Borne and Infectious Disease Research Center, Tulane University, 1440 Canal St., New Orleans, La 70112, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Corresponding author: <email>au.arnal@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2018</year>
</pub-date>
<elocation-id>423145</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="423145.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<sec>
<title>Background</title>
<p>In Mexico, estimates of Chagas disease prevalence and burden vary widely. Updating surveillance data is therefore an important priority to ensure that Chagas disease does not remain a barrier to the development of Mexico&#x2019;s most vulnerable populations.</p>
</sec>
<sec>
<title>Methodology/Principal Findings</title>
<p>The aim of this systematic review was to analyze the literature on epidemiological surveys to estimate Chagas disease prevalence and burden in Mexico, during the period 2006 to 2017. A total of 2,764 articles were screened and 38 were retained for the final analysis. Epidemiological surveys have been performed in most of Mexico, but with variable geographic coverage. Based on studies reporting confirmed cases, i.e. using at least 2 serological tests, the national seroprevalence of <italic>Trypanosoma cruzi</italic> infection was 2.26&#x0025; [95&#x0025; Confidence Interval (CI) 2.12-2.41], suggesting that there are 2.71 million cases in Mexico. Studies focused on pregnant women, which may transmit the parasite to their newborn during pregnancy, reported a seroprevalence of 1.00&#x0025; [95&#x0025; CI 0.87-1.14], suggesting that there are 22,930 births from <italic>T. cruzi</italic> infected pregnant women per year, and 1,445 cases of congenitally infected newborns per year. Children under 18 years had a seropositivity rate of 1.49&#x0025; [95&#x0025; CI 1.20-1.85], which indicate ongoing transmission. Finally, cases of <italic>T. cruzi</italic> infection in blood donors have also been reported in most states, with a national seroprevalence of 0.51&#x0025; [95&#x0025; CI 0.49-0.53].</p>
</sec>
<sec>
<title>Conclusions/Significance</title>
<p>Our analysis suggests a disease burden for <italic>T. cruzi</italic> infection higher than previously recognized, highlighting the urgency of establishing Chagas disease surveillance and control as a key national public health priority in Mexico, to ensure that it does not remain a major barrier to the economic and social development of the country&#x2019;s most vulnerable populations.</p>
</sec>
<sec>
<title><bold>Author summary</bold></title>
<p>In Mexico, estimates of Chagas disease prevalence and burden vary widely due to the ecology and epidemiology of this disease resulting of many geographical, ecological, biological, and social interactions. Better data are thus urgently needed to help develop appropriate public health programs for disease control and patient care. In this study we analyzed published data on <italic>T. cruzi</italic> seroprevalence infection in Mexico between 2006 and 2017. This systematic review shows a national seroprevalence of <italic>T. cruzi</italic> infection of 2.26&#x0025; [95&#x0025;CI 2.12-2.41], with over 2.71 million cases in Mexico, which is higher than previously recognized. The presence of <italic>T. cruzi</italic> infection in specific subpopulations such as pregnant women, children and blood donors also informs on specific risks of infection and call for the implementation of well-established control interventions. This work confirms the place of Mexico as the country with the largest number of cases, highlighting the urgency of establishing Chagas disease control as a key national public health priority.</p>
</sec>
</abstract>
<counts>
<page-count count="32"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Chagas disease or American trypanosomiasis is an infection caused by the protozoan parasite <italic>Trypanosoma cruzi</italic>, which is mainly transmitted to humans and other mammals through the contaminated feces of hematophagous bugs called triatomines (family Reduviidae). However, it can also be spread via non-vectorial routes, such as blood transfusion, congenital transmission, organ transplantation, ingestion of food and beverages contaminated with <italic>T. cruzi</italic> or laboratory accidents [<xref rid="c1" ref-type="bibr">1</xref>]. Over the years, infection with <italic>T. cruzi</italic> can cause heart failure or sudden death associated with progressive heart damage [<xref rid="c2" ref-type="bibr">2</xref>]. Some patients may also suffer from digestive, neurological or multiple alterations. This disease, classified by the World Health Organization (WHO) within the group of neglected tropical diseases, is a major public health problem in Latin America where it is estimated that 6 to 7 million people are currently infected [<xref rid="c1" ref-type="bibr">1</xref>]. Due to human migrations, Chagas disease is emerging in other regions (Europe and United States principally) [<xref rid="c3" ref-type="bibr">3</xref>]. Estimates suggest that 80,000 to 120,000 <italic>T. cruzi</italic>-infected immigrants live in Europe, and 300,000 live in the United States [<xref rid="c4" ref-type="bibr">4</xref>], and the disease is a growing concern in these regions [<xref rid="c5" ref-type="bibr">5</xref>]. The global economic burden of Chagas disease is more than US&#x0024; 7.2 billion per year, exceeding the costs of other diseases of health impact such as certain cancer (US&#x0024;6.7 billion for uterine cancer, US&#x0024;4.7 billion for cervical cancer, and US&#x0024;5.3 billion for oral cancer) or rotavirus infections (US&#x0024; 2 billion) [<xref rid="c6" ref-type="bibr">6</xref>,<xref rid="c7" ref-type="bibr">7</xref>].</p>
<p>In Mexico, estimates of Chagas disease prevalence and burden vary widely, which has complicated the establishment of a strong National Chagas Disease Program for vector control as well as for patient detection and care in the country. For the past several years, the Ministry of Health only reports a few hundred cases per year [<xref rid="c8" ref-type="bibr">8</xref>], suggesting that the disease has an anecdotal burden in terms of public health. On the other hand, other estimates suggest that there are about 1.1 million individuals infected with <italic>T. cruzi</italic> in Mexico, and 29.5 million at risk of infection [<xref rid="c9" ref-type="bibr">9</xref>,<xref rid="c10" ref-type="bibr">10</xref>]. Higher estimates of up to 6 million cases have also been proposed [<xref rid="c11" ref-type="bibr">11</xref>]. The annual cost for medical care for patients in the outpatient setting in this country is estimated between US&#x0024;4,463 and US&#x0024;9,601, and annual costs for patients admitted via an emergency care unit is between US&#x0024;6,700 and US&#x0024;11,838 [<xref rid="c12" ref-type="bibr">12</xref>].</p>
<p>There are also important regional differences in prevalence levels or number of cases reported in Mexico. For example, between 1928 and 2004 the states with the highest number of human cases reported were Chiapas, Guerrero, Jalisco, Morelos, Nayarit, Oaxaca and Queretaro. Conversely, few cases were reported in the states of Chihuahua, Coahuila, Guanajuato and Estado de Mexico [<xref rid="c11" ref-type="bibr">11</xref>]. It is not clear if such differences in prevalence are reflecting true differences in eco-epidemiological conditions, as Mexico is home to an extensive diversity of triatomine species, habitats, and socioeconomic conditions, or if there are bias in disease surveillance among regions [<xref rid="c11" ref-type="bibr">11</xref>].</p>
<p>Such wide discrepancies are important to reconcile to ensure that Chagas disease does not remain a major barrier to the development of Mexico&#x2019;s most vulnerable populations. Updating and improving surveillance data for Chagas disease in Mexico is therefore an important public health priority. In this context, the aim of this systematic review was to analyze available literature on epidemiological surveys to estimate Chagas disease prevalence and burden in Mexico. We focused our study on the period from 2006 to 2017, to define current disease status rather than historical/cumulative burden, but our results are nonetheless compared with past reviews [<xref rid="c11" ref-type="bibr">11</xref>,<xref rid="c13" ref-type="bibr">13</xref>,<xref rid="c14" ref-type="bibr">14</xref>] to shed light on possible temporal trends on the status of Chagas disease in the country.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<p>This systematic review was conducted in accordance with the PRISMA statement [<xref rid="c15" ref-type="bibr">15</xref>] (Supporting information). Potential data sources were identified and selected in different bibliographic databases. The ISI Web of Science (v5.13.1) was chosen because it incorporates many relevant databases including the SciELO Citation Index from 1997 onwards (provides access to leading journals from Latin America, Portugal, Spain and South Africa) and the Web of Science&#x2019;s Core Collection from 1980 onwards (<ext-link ext-link-type="uri" xlink:href="https://webofknowledge.com/">https://webofknowledge.com/</ext-link>). A part of the literature was selected from the LILACS database (lilacs.bvsalud.org/en/), which is the most important index of scientific and technical literature of Latin America and the Caribbean. Finally, the BibTri database (<ext-link ext-link-type="uri" xlink:href="https://bibtri.cepave.edu.ar/">https://bibtri.cepave.edu.ar/</ext-link>) was also used because it integrates scientific literature specifically related to Chagas disease.</p>
<p>We restricted our search to the period from January 2006 to December 2017, to obtain information on the current status of Chagas disease in Mexico rather than on its historical/cumulative status, which has been summarized in previous reviews [<xref rid="c11" ref-type="bibr">11</xref>,<xref rid="c13" ref-type="bibr">13</xref>,<xref rid="c14" ref-type="bibr">14</xref>]. Selection was made using the search terms &#x2018;Chagas disease in Mexico/Enfermedad de Chagas en M&#x00E9;xico&#x2019;.</p>
<p>For all these articles, titles and abstracts were screened for any indication that the study contained data related to the seroprevalence of <italic>T. cruzi</italic> infection in human populations from Mexico. Typically, this excluded studies of, for example, therapeutic options for patients with chronic Chagas disease, molecular studies of lab strains of the parasite, or experimental model developments (<xref rid="fig1" ref-type="fig">Figure 1</xref>). In the second step of the process, full text copies were obtained and articles containing quantitative data on <italic>T. cruzi</italic> infection seroprevalence were retained. Extreme care was taken in cross-validating whether the information contained in each study was unique and not duplicated elsewhere.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Process flow chart for the identification, screening, eligibility, and inclusion of studies.</title></caption>
<graphic xlink:href="423145_fig1.tif"/>
</fig>
<p>The ultimate step was to extract the relevant information contained in the selected articles which included 1) publication data (bibliographic information), 2) sampling dates, 3) sampling strategy (archive, random, volunteers, etc&#x2026;), 4) geographic area covered by the study, 5) studied population (blood donors, patients, pregnant women, newborns, children, random populations), 6) laboratory techniques used (ELISA tests; IHA, PCR&#x2026;) and their validation, 7) total sample size, number of human cases, and reported prevalence. If no prevalence was reported, it was calculated from the total of sample size and the number of human cases of <italic>T. cruzi</italic> seropositivity. We further calculated 95&#x0025; confidence intervals (95&#x0025;CI) based on the reported data and sample sizes [<xref rid="c16" ref-type="bibr">16</xref>,<xref rid="c17" ref-type="bibr">17</xref>]. The prevalences obtained were compared to the data reported by the Ministry of Health and with other reviews [<xref rid="c8" ref-type="bibr">8</xref>]. Studied populations were divided into subgroups to allow for analysis of the seroprevalence of <italic>T. cruzi</italic> infection at different levels, including the general population, pregnant women, children, and blood donors.</p>
</sec>
<sec id="s3">
<title>Results</title>
<p>A total of 2,764 articles were screened and 38 were retained for the final analysis (see <xref rid="fig1" ref-type="fig">Figure 1</xref>). 1) All the articles included in this study corresponded to serological surveys in different populations and settings, including general or specific populations such as pregnant women or blood donors, published between 2006 and 2017 (<xref rid="tbl1" ref-type="table">Table 1</xref>). Research on Chagas disease seroprevalence has been performed in most of the Mexican Republic (<xref rid="fig2" ref-type="fig">Figure 2</xref>), although the number and scale of the studies varied greatly. The states with more studies were Veracruz, Yucatan, and Queretaro.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1:</label>
<caption><p>Characteristics of included studies.</p></caption>
<graphic xlink:href="423145_tbl1.tif"/>
<graphic xlink:href="423145_tbl1a.tif"/>
<graphic xlink:href="423145_tbl1b.tif"/>
</table-wrap>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><title>Number of publications which report human cases of <italic>T. cruzi</italic> seropositivity from states of Mexico, 2006-2017. Each publication can cover several states.</title></caption>
<graphic xlink:href="423145_fig2.tif"/>
</fig>
<p>We first considered the studies in random populations and in pregnant women (which can be considered as highly representative of the general population as well [<xref rid="c55" ref-type="bibr">55</xref>]). When considering all studies, irrespective of the inclusion of confirmatory diagnostic (i.e. based on a single serological test, 29 studies), the total number of human cases reported in the literature during the period 2006-2017 was 1,147 with a national prevalence of 2.74&#x0025; [95&#x0025;CI 2.59-2.90] in the general population (<xref rid="tbl2" ref-type="table">Table 2</xref>). Seroprevalence of infection varied between 0.21&#x0025; and 9.13&#x0025; depending on the state. Only 3 studies were based on a single test and when considering only the studies in which at least 2 serological tests had been performed (26 studies), hence cases had been confirmed as currently recommended by the WHO for an accurate identification of cases, the national seroprevalence was 2.26&#x0025; [95&#x0025;CI 2.12-2.41], with seroprevalences between 0.21&#x0025; and 12.01&#x0025; depending on the state (<xref rid="tbl3" ref-type="table">Table 3</xref>). The highest seroprevalence levels were reported in the states of Jalisco, San Luis Potosi, Chiapas, Estado de Mexico, Queretaro, and Oaxaca. Based on a national population of nearly 120 million (National census of 2015), this seroprevalence level would correspond to 2.71 million cases in the country [95&#x0025;CI 1.55-3.20 million]. On the other hand, the number of cases of <italic>T. cruzi</italic> infection reported by the national program of epidemiologic surveillance of the Ministry of Health during 2006-2017 period reached 8,687 ([<xref rid="c8" ref-type="bibr">8</xref>] and <xref rid="tbl4" ref-type="table">Table 4</xref>), with a regular increase in the number of cases detected with time.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2:</label>
<caption><p>Cases of <italic>Trypanososma cruzi</italic> infection detected in serological surveys of general populations and pregnant women during 2006-2017 (29 studies).</p></caption>
<graphic xlink:href="423145_tbl2.tif"/>
</table-wrap>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3:</label>
<caption><p>Confirmed cases of <italic>Trypanososma cruzi</italic> infection detected in serological surveys of general populations and pregnant women during 2006-2017 (26 studies).</p></caption>
<graphic xlink:href="423145_tbl3.tif"/>
</table-wrap>
<table-wrap id="tbl4" orientation="portrait" position="float">
<label>Table 4:</label>
<caption><p>Number of new cases of Chagas disease per years, reported by the Ministry of Health, in all the states of Mexico [<xref rid="c8" ref-type="bibr">8</xref>].</p></caption>
<graphic xlink:href="423145_tbl4.tif"/>
</table-wrap>
<p>A few of these studies (7 studies) focused on pregnant women, which may transmit the parasite to their newborn during pregnancy [<xref rid="c56" ref-type="bibr">56</xref>]. While these studies only covered 7 states (<xref rid="tbl5" ref-type="table">Table 5</xref>), a total of 212 <italic>T. cruzi</italic>-infected pregnant women were detected, for a global seroprevalence of <italic>T. cruzi</italic> infection of 1.00&#x0025; [95&#x0025;CI 0.87-1.14] in this specific population. The highest seroprevalence levels in pregnant women were reported in the states of Jalisco, Oaxaca, and Estado de Mexico. Based on current birth rate in Mexico (2,293,000 births in 2016), this would correspond to 22,930 births from <italic>T. cruzi</italic> infected pregnant women per year. With a congenital transmission rate of 6.3&#x0025; [<xref rid="c21" ref-type="bibr">21</xref>], there may be 1,445 cases of congenitally infected newborns per year in the country.</p>
<table-wrap id="tbl5" orientation="portrait" position="float">
<label>Table 5:</label>
<caption><p>Prevalence of positive pregnant women by state, 2006-2017 (7 studies).</p></caption>
<graphic xlink:href="423145_tbl5.tif"/>
</table-wrap>
<p>Some studies also focused on or included data on children under 18 years (6 studies), which may indicate more recent transmission. These covered only 4 states (<xref rid="tbl6" ref-type="table">Table 6</xref>), with a global seroprevalence of <italic>T. cruzi</italic> infection of 1.49&#x0025; [95&#x0025;CI 1.20-1.85].</p>
<table-wrap id="tbl6" orientation="portrait" position="float">
<label>Table 6:</label>
<caption><p>Prevalence of positive children under 18 years by state, 2006-2017 (6 studies).</p></caption>
<graphic xlink:href="423145_tbl6.tif"/>
</table-wrap>
<p>Several studies also evaluated <italic>T. cruzi</italic> infection in blood donors (9 studies), and positive human cases were detected in every state of the Mexican Republic, except for Baja California Sur, Sinaloa, and Zacatecas (<xref rid="tbl7" ref-type="table">Table 7</xref>). The total number of blood donor cases reported was 2,300, corresponding to a national seroprevalence of 0.51&#x0025; [95&#x0025;CI 0.49-0.53]. The highest seroprevalence was observed in the states of Quintana Roo, Tabasco, Puebla, Campeche and Nayarit.</p>
<table-wrap id="tbl7" orientation="portrait" position="float">
<label>Table 7:</label>
<caption><p>Prevalence of positive serology in blood banks by state, 2006-2017 (9 studies).</p></caption>
<graphic xlink:href="423145_tbl7.tif"/>
<graphic xlink:href="423145_tbl7a.tif"/>
</table-wrap>
<p>Finally, we also examined the type of serological test performed in these studies. The most widely used tests were indirect hemagglutination, followed by Chagatest ELISA from Wiener lab, and immunifluorescence assays (<xref rid="tbl8" ref-type="table">Table 8</xref>), which represented 65&#x0025; of all tests used. Several other commercial ELISA tests were also used (24&#x0025; of tests), and in-house tests including ELISA, microscopy and western blot represented 5.7&#x0025; of the tests used.</p>
<table-wrap id="tbl8" orientation="portrait" position="float">
<label>Table 8:</label>
<caption><p>Type of diagnostic tests used in epidemiological studies in Mexico</p></caption>
<graphic xlink:href="423145_tbl8.tif"/>
</table-wrap>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>Chagas disease remains one of the most relevant parasitic disease in the Americas, but its epidemiology in Mexico is still poorly understood. Better data are thus urgently needed to help develop appropriate public health programs for disease control and patient care. In this study we analyzed published data on <italic>T. cruzi</italic> seroprevalence of infection in Mexico between 2006 and 2017. A total of 38 studies were identified, covering most of the country with the notable exception of the state of Michoac&#x00E1;n. Discrepancies in previous studies have been often attributed to diagnostic methods and uncertainties about the confirmation of cases [<xref rid="c57" ref-type="bibr">57</xref>], leading to current recommendations of health agencies requesting a minimum of 2 serological techniques for accurate diagnostic [<xref rid="c10" ref-type="bibr">10</xref>]. Based on this criterion, we found a national seroprevalence of <italic>T. cruzi</italic> infection of 2.26&#x0025;, corresponding to 2.71 million cases in the country. Importantly, few studies were discarded for lack of confirmatory testing, indicating that most of recent studies followed current guidelines for the accurate diagnostic of cases. This seroprevalence level can thus be considered rather conservative, but it is much higher than previous estimates. For example, the Pan American Health Organization (PAHO) estimated that 1,100,000 individuals were infected with <italic>T. cruzi</italic> in Mexico in 2006, and 29,500,000 were at risk of infection [<xref rid="c58" ref-type="bibr">58</xref>], and a national prevalence of 0.65&#x0025; (with 733,333 cases) was established in 2010 by the Mexican Ministry of Health [<xref rid="c59" ref-type="bibr">59</xref>]. The most recent estimates from the WHO based on 2010 data reports 876,458 cases (WHO 2015 epidemiological record), corresponding to a national prevalence of 0.78&#x0025;. Our analysis of data from the last decade thus suggests that the magnitude of <italic>T. cruzi</italic> infection in Mexico may have been underestimated in these previous reports. In addition, recent studies pointing out a low sensitivity of commercial serological tests for <italic>T. cruzi</italic> diagnostic [<xref rid="c21" ref-type="bibr">21</xref>,<xref rid="c31" ref-type="bibr">31</xref>,<xref rid="c60" ref-type="bibr">60</xref>], some of which are well used in Mexico (<xref rid="tbl8" ref-type="table">Table 8</xref>) also raise concerns that the seroprevalence of <italic>T. cruzi</italic> infection may even be higher than currently detected. Improvements in serological tests are thus urgently needed for a more reliable disease surveillance [<xref rid="c61" ref-type="bibr">61</xref>]. Our analysis nonetheless places Mexico as the country with the largest number of cases of <italic>T. cruzi</italic> infection as previously estimated [<xref rid="c10" ref-type="bibr">10</xref>], and highlight the urgency of establishing national priorities for the control of parasite transmission and patient care as well as improved epidemiologic surveillance.</p>
<p>Our results also point out to some regional differences in <italic>T. cruzi</italic> infection seroprevalence among states. The ecology and epidemiology of Chagas disease are the result of many geographical, ecological, biological, and social interactions [<xref rid="c62" ref-type="bibr">62</xref>], which may explain some of these differences. High seroprevalence levels have been previously reported for several states including Jalisco, Chiapas, Queretaro, Oaxaca, Veracruz, and Morelos [<xref rid="c11" ref-type="bibr">11</xref>], suggesting a well-established endemicity in these states. States with seroprevalence levels higher than previously reported also emerged through our study, in spite of limited sample sizes. These include San Luis Potosi, Estado de Mexico, Hidalgo and Guanajuato.</p>
<p><italic>T. cruzi</italic> infection is also present at a significant seroprevalence in pregnant women in Mexico. Despite the limited information available for this specific population, we could estimate that there are 22,930 births from <italic>T. cruzi</italic> infected pregnant women per year, corresponding to 1,445 cases of congenitally infected newborns per year in the country. This is very similar to previous estimates [<xref rid="c63" ref-type="bibr">63</xref>], suggesting that the epidemiology of congenital Chagas disease has not changed in the past decade. Because infected newborns can be effectively treated, the lack of specific screening programs to identify them is a missed opportunity for the control of the disease. Indeed, a recent health economic study in the US evidenced the large benefits of maternal screening for <italic>T. cruzi</italic> infection, as lifetime societal savings due to screening and treatment was estimated at &#x0024;634 million saved for every birth year cohort [<xref rid="c64" ref-type="bibr">64</xref>].</p>
<p>Very limited information is available on <italic>T. cruzi</italic> infection in children. Nonetheless, we were able to identify a few studies on children up to 18 years, who presented an average prevalence of 1.49&#x0025;. This may indicate more recent and active transmission compared to data on adult populations, and suggests that the incidence of <italic>T. cruzi</italic> infection has been fairly stable over time. Therefore, effective vector control programs tailored to the extensive diversity of triatomine species present in Mexico [<xref rid="c65" ref-type="bibr">65</xref>] are urgently needed to reduce vectorial <italic>T. cruzi</italic> transmission to human populations [<xref rid="c66" ref-type="bibr">66</xref>,<xref rid="c67" ref-type="bibr">67</xref>].</p>
<p>Blood transfusion has been considered the second most important mode of transmission of Chagas disease in Mexico [<xref rid="c68" ref-type="bibr">68</xref>]. In 1998, the screening of almost 65,000 blood donors from 18 government-run transfusion centers showed a 1.5&#x0025; prevalence of anti-<italic>T. cruzi</italic> antibodies in blood donors [<xref rid="c69" ref-type="bibr">69</xref>]. The highest prevalence was detected in the states of Hidalgo, Tlaxcala, Puebla, Chiapas y Yucatan, as expected from previous reports, whereas the northern states of Nuevo Leon and Chihuahua, had the lowest seroprevalence in blood donors. For the period between 1978-2004, Cruz-Reyes <italic>et al.</italic> defined a national prevalence of positive serology in blood banks of 2.03&#x0025; [<xref rid="c11" ref-type="bibr">11</xref>]. In our study, the national prevalence detected in blood donors was lower with 0.51&#x0025;. These differences can be explained by the increased reliability of serologic screening of blood donors with the passing of legislation making screening mandatory in the year 2000 [<xref rid="c13" ref-type="bibr">13</xref>,<xref rid="c70" ref-type="bibr">70</xref>]. The highest prevalence of 1.99&#x0025; is detected in the state of Quintana Roo and the lowest in Baja California Sur, Sinaloa and Zacatecas (with a prevalence of 0&#x0025;).</p>
</sec>
<sec id="s5">
<title>Strengths and limitations</title>
<p>A major strength of our analysis was to consider the reliability of serological testing performed, and to ensure it followed WHO recommendation for confirmation of cases using at least a second test. Hence, our estimates of seroprevalence are robust and conservative. On the other hand, there are some limitations. First, some heterogeneity among study designs and particularly sampling strategies and recruitment of subjects may have generated some bias. Also, publication bias leading to uneven coverage of the different states by research studies may be a confounding factor affecting differences in <italic>T. cruzi</italic> infection prevalence among states, and may also affect the national average, as we did not attempt to weigh studies based on sample sizes and state population. This highlights the need for much improved nationwide disease surveillance to clearly identify geographic heterogeneities in <italic>T. cruzi</italic> transmission and Chagas disease epidemiology. Finally, the small number of studies/sample sizes for some of the subgroup analysis also add uncertainties to our estimates of <italic>T. cruzi</italic> seroprevalence in subpopulations.</p>
</sec>
<sec id="s6">
<title>Conclusion</title>
<p>In conclusion, our systematic review shows a national seroprevalence of <italic>T. cruzi</italic> infection of 2.26&#x0025;, with 2.71 million cases in Mexico, which is higher than previously recognized. It places Mexico as the country with the largest number of cases, highlighting the urgency of establishing Chagas disease control as a key national public health priority, to ensure that it does not remain a major barrier to the economic and social development of Mexico&#x2019;s most vulnerable populations. The presence of <italic>T. cruzi</italic> infection in specific subpopulations such as pregnant women, children and blood donors also informs on specific risks of infection, and call for the implementation of well-established control interventions [<xref rid="c56" ref-type="bibr">56</xref>,<xref rid="c67" ref-type="bibr">67</xref>,<xref rid="c71" ref-type="bibr">71</xref>]. It also remains essential to strengthen effective nationwide surveillance for Chagas disease, in order to obtain more precise data on its prevalence across the country and its changes over time. Finally, while our estimates are conservative and based on confirmed cases, the lack of sensitivity of current serological tests observed in Mexico suggest that the true magnitude of Chagas disease in the country may still be underestimated, and the development of more reliable diagnostic tests will be key for an effective identification of cases as well as improved patient care [<xref rid="c61" ref-type="bibr">61</xref>].</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Dr. Pierre Buekens for his helpful comments on a draft version of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="website"><collab>WHO</collab>. <source>Chagas disease (American trypanosomiasis), Fact sheet N&#x00B0;340</source>. Available at <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs340/en/">http://www.who.int/mediacentre/factsheets/fs340/en/</ext-link>. <year>2017</year>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="book"><string-name><surname>Rassi</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Rassi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Marin-Neto</surname> <given-names>JA</given-names></string-name>. <chapter-title>Chagas disease</chapter-title>. <source>Lancet</source>. <publisher-name>Elsevier Ltd</publisher-name>; <year>2010</year>;<volume>375</volume>: <fpage>1388</fpage>&#x2013;<lpage>1402</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(10)60061-X</pub-id></mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="book"><string-name><surname>Schmunis</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Yadon</surname> <given-names>ZE</given-names></string-name>. <chapter-title>Chagas disease: A Latin American health problem becoming a world health problem</chapter-title>. <source>Acta Trop</source>. <publisher-name>Elsevier B.V</publisher-name>.; <year>2010</year>;<volume>115</volume>: <fpage>14</fpage>&#x2013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.actatropica.2009.11.003</pub-id></mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Soriano-Arandes</surname> <given-names>A</given-names></string-name>, <string-name><surname>Angheben</surname> <given-names>A</given-names></string-name>, <string-name><surname>Serre-Delcor</surname> <given-names>N</given-names></string-name>, <string-name><surname>Trevi&#x00F1;o-Maruri</surname> <given-names>B</given-names></string-name>, <string-name><surname>G&#x00F3;mez</surname> <given-names>I</given-names></string-name> <string-name><surname>Prat</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>Y.</given-names></string-name> <article-title>Control and management of congenital Chagas disease in Europe and other non-endemic countries: Current policies and practices</article-title>. <source>Trop Med Int Heal</source>. <year>2016</year>;<volume>21</volume>: <fpage>590</fpage>&#x2013;<lpage>596</lpage>. doi:<pub-id pub-id-type="doi">10.1111/tmi.12687</pub-id></mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Nunes</surname> <given-names>MCP</given-names></string-name>, <string-name><surname>Beaton</surname> <given-names>A</given-names></string-name>, <string-name><surname>Acquatella</surname> <given-names>H</given-names></string-name>, <string-name><surname>Bern</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bolger</surname> <given-names>AF</given-names></string-name>, <string-name><surname>Echeverr&#x00ED;a</surname> <given-names>LE</given-names></string-name>, <etal>et al.</etal> <article-title>Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association [Internet]</article-title>. <source>Circulation</source>. <year>2018</year>. doi:<pub-id pub-id-type="doi">10.1161/CIR.0000000000000599</pub-id></mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname> <given-names>BY</given-names></string-name>, <string-name><surname>Bacon</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Bottazzi</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Hotez</surname> <given-names>PJ</given-names></string-name>. <article-title>Global economic burden of Chagas disease: a computational simulation model</article-title>. <source>Lancet Infect Dis</source>. <year>2013</year>;<volume>13</volume>: <fpage>342</fpage>&#x2013;<lpage>348</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(13)70002-1.Global</pub-id></mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><collab>GBD</collab> <year>2013</year> <article-title>Mortality and causes of death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013</article-title>. <source>Lancet</source>. 2015;<volume>385</volume>: <fpage>117</fpage>&#x2013;<lpage>171</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="website"><collab>Direcci&#x00F3;n General de Epidemiolog&#x00ED;a</collab>. <source>Anuarios de morbilidad, informaci&#x00F3;n de epidemiol&#x00F3;gica Secretar&#x00ED;a de Salud 1984&#x2013;2013</source>. <year>2006</year>. Available at <ext-link ext-link-type="uri" xlink:href="http://www.epidemiologia.salud.gob.mx/anuario/html/anuarios.html">http://www.epidemiologia.salud.gob.mx/anuario/html/anuarios.html</ext-link>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Hotez</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Dumonteil</surname> <given-names>E</given-names></string-name>, <string-name><surname>Betancourt Cravioto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bottazzi</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Tapia-Conyer</surname> <given-names>R</given-names></string-name>, <string-name><surname>Meymandi</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>An unfolding tragedy of Chagas disease in North America</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>;<volume>7</volume>: <fpage>e</fpage>&#x2013;<lpage>2300</lpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pntd.0002300</pub-id></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <article-title>Chagas disease in Latin America: an epidemiological update based on 2010 estimates</article-title>. <source>Wkly Epidemiol Rec</source>. <year>2015</year>; doi:<pub-id pub-id-type="doi">10.2147/IBPC.S70402</pub-id></mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Cruz-Reyes</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pickering-L&#x00F3;pez</surname> <given-names>JM</given-names></string-name>. <article-title>Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years-A review</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2006</year>;<volume>101</volume>: <fpage>345</fpage>&#x2013;<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0074-02762006000400001</pub-id></mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Ramsey</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Elizondo-Cano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sanchez-Gonz&#x00E1;lez</surname> <given-names>G</given-names></string-name>, <string-name><surname>Pe&#x00F1;a-Nieves</surname> <given-names>A</given-names></string-name>, <string-name><surname>Figueroa-Lara</surname> <given-names>A.</given-names></string-name> <article-title>Opportunity cost for early treatment of Chagas disease in Mexico</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2014</year>;<volume>8</volume>: <fpage>e2776</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pntd.0002776</pub-id></mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Guzman-Bracho</surname> <given-names>C.</given-names></string-name> <article-title>Epidemiology of Chagas disease in Mexico: an update</article-title>. <source>Trends Parasitol</source>. <year>2001</year>;<volume>17</volume>: <fpage>372</fpage>&#x2013;<lpage>376</lpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Dumonteil</surname> <given-names>E.</given-names></string-name> <article-title>Update on Chagas&#x2019; disease in Mexico</article-title>. <source>Salud Publica Mex</source>. <year>1999</year>;<volume>41</volume>: <fpage>322</fpage>&#x2013;<lpage>327</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Liberati</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tetzlaff</surname> <given-names>J</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><given-names>The PRISMA</given-names> <surname>Group</surname></string-name>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</article-title>. <source>PLoS Med</source>. <year>2009</year>;<volume>6</volume>: <fpage>e1000097</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id></mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Newcombe</surname> <given-names>RG</given-names></string-name>. <article-title>Two-sided confidence intervals for the single proportion: Comparison of seven methods</article-title>. <source>Stat Med</source>. <year>1998</year>; doi:<pub-id pub-id-type="doi">10.1002/(SICI)1097-0258(19980430)17:8&#x003C;857::AID-SIM777&#x003E;3.0.CO;2-E</pub-id></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Wilson</surname> <given-names>EB</given-names></string-name>. <article-title>Probable inference, the law of succession, and statistical inference</article-title>. <source>J Am Stat Assoc</source>. <year>1927</year>; doi:<pub-id pub-id-type="doi">10.1080/01621459.1927.10502953</pub-id></mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Balan</surname> <given-names>LU</given-names></string-name>, <string-name><surname>Yerbes</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Pi&#x00F1;a</surname> <given-names>MAN</given-names></string-name>, <string-name><surname>Balmes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pascual</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez</surname> <given-names>O</given-names></string-name>, <etal>et al.</etal> <article-title>Higher seroprevalence of <italic>Trypanosoma cruzi</italic> infection in dogs than in Humans in an urban area of Campeche, Mexico</article-title>. <source>Vector-Borne Zoonotic Dis</source>. <year>2011</year>;<volume>11</volume>: <fpage>843</fpage>&#x2013;<lpage>844</lpage>. doi:<pub-id pub-id-type="doi">10.1089/vbz.2010.0039</pub-id></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Becerril-Flores</surname> <given-names>M a</given-names></string-name>, <string-name><surname>Rangel-Flores</surname> <given-names>E</given-names></string-name>, <string-name><surname>Imbert-Palafox</surname> <given-names>JL</given-names></string-name>, <string-name><surname>G&#x00F3;mez-G&#x00F3;mez</surname> <given-names>JV</given-names></string-name>, <string-name><surname>Figueroa-Guti&#x00E9;rrez</surname> <given-names>AH</given-names></string-name>. <article-title>Human infection and risk of transmission of Chagas disease in Hidalgo state, Mexico</article-title>. <source>Am J Trop Med Hyg</source>. <year>2007</year>;<volume>76</volume>: <fpage>318</fpage>&#x2013;<lpage>23</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17297042">http://www.ncbi.nlm.nih.gov/pubmed/17297042</ext-link></mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Breni&#x00E8;re</surname> <given-names>SF</given-names></string-name>, <string-name><surname>Bosseno</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Magall&#x00F3;n-GasteL&#x00FA;m</surname> <given-names>E</given-names></string-name>, <string-name><surname>Castillo Ruvalcaba</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Gutierrez</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Monta&#x00F1;o Luna</surname> <given-names>EC</given-names></string-name>, <etal>et al.</etal> <article-title>Peridomestic colonization of <italic>Triatoma longipennis</italic> (Hemiptera, Reduviidae) and <italic>Triatoma barberi</italic> (Hemiptera, Reduviidae) in a rural community with active transmission of <italic>Trypanosoma cruzi</italic> in Jalisco state, Mexico</article-title>. <source>Acta Trop</source>. <year>2007</year>;<volume>101</volume>: <fpage>249</fpage>&#x2013;<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.actatropica.2007.02.007</pub-id></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Buekens</surname> <given-names>P</given-names></string-name>, <string-name><surname>Cafferata</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Alger</surname> <given-names>J</given-names></string-name>, <string-name><surname>Althabe</surname> <given-names>F</given-names></string-name>, <string-name><surname>Beliz&#x00E1;n</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Bustamante</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal> <article-title>Congenital transmission of <italic>Trypanosoma cruzi</italic> in Argentina, Honduras, and Mexico: An observational prospective study</article-title>. <source>Am J Trop Med Hyg</source>. <year>2018</year>;<volume>98</volume>: <fpage>478</fpage>&#x2013;<lpage>485</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.17-0516</pub-id></mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Campos-Valdez</surname> <given-names>G</given-names></string-name>, <string-name><surname>Canseco-&#x00C1;vila</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Noriega</surname> <given-names>F</given-names></string-name>, <string-name><surname>Alfaro-Zebadua</surname> <given-names>O</given-names></string-name>, <string-name><surname>Nava-Medecigo</surname> <given-names>IY</given-names></string-name>, <string-name><surname>Jim&#x00E9;nez-Cardoso</surname> <given-names>E.</given-names></string-name> <article-title>Transmisi&#x00F3;n materno-fetal de <italic>Trypanosoma cruzi</italic>, un problema de salud poco estudiado en M&#x00E9;xico: Caso Chiapas</article-title>. <source>Salud Publica Mex</source>. <year>2016</year>;<volume>58</volume>: <fpage>378</fpage>&#x2013;<lpage>384</lpage>. doi:<pub-id pub-id-type="doi">10.21149/spm.v58i3.7898</pub-id></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Cenalmor-Aparicio</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ballinas-Verdugo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Reyes</surname> <given-names>PA</given-names></string-name>. <article-title>Trypanosomosis americana (enfermedad de Chagas) en el municipio de Chil&#x00F3;n, Chiapas: una encuesta cl&#x00ED;nicoepidemiol&#x00F3;gica en 2011</article-title>. <source>Salud Publica Mex</source>. <year>2013</year>;<volume>55</volume>: <fpage>149</fpage>&#x2013;<lpage>150</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Dhiman</surname> <given-names>M</given-names></string-name>, <string-name><surname>Estrada-Franco</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Pando</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Ramirez-Aguilar</surname> <given-names>FJ</given-names></string-name>, <string-name><surname>Spratt</surname> <given-names>H</given-names></string-name>, <string-name><surname>Vazquez-Corzo</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas&#x2019; disease</article-title>. <source>Clin Vaccine Immunol</source>. <year>2009</year>;<volume>16</volume>: <fpage>660</fpage>&#x2013;<lpage>666</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CVI.00019-09</pub-id></mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Escamilla-Guerrero</surname> <given-names>G</given-names></string-name>, <string-name><surname>Mart&#x00ED;nez-Gordillo</surname> <given-names>MN</given-names></string-name>, <string-name><surname>River&#x00F5;n-Negrete</surname> <given-names>L</given-names></string-name>, <string-name><surname>Aguilar-Escobar</surname> <given-names>DV</given-names></string-name>, <string-name><surname>Bravo-Lindoro</surname> <given-names>A</given-names></string-name>, <string-name><surname>Cob-Sosa</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title><italic>Trypanosoma cruzi</italic>: Seroprevalence detected in the blood bank of the Instituto Nacional de Pediatr&#x00ED;a, Mexico City, in the period 2004 through 2009</article-title>. <source>Transfusion</source>. <year>2012</year>;<volume>52</volume>: <fpage>595</fpage>&#x2013;<lpage>600</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1537-2995.2011.03322.x</pub-id></mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Estrada-Franco</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Bhatia</surname> <given-names>V</given-names></string-name>, <string-name><surname>Diaz-Albiter</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ochoa-Garcia</surname> <given-names>L</given-names></string-name>, <string-name><surname>Barbabosa</surname> <given-names>A</given-names></string-name>, <string-name><surname>Vazquez-Chagoyan</surname> <given-names>JC</given-names></string-name>, <etal>et al.</etal> <article-title>Human <italic>Trypanosoma cruzi</italic> infection and seropositivity in dogs, Mexico</article-title>. <source>Emerg Infect Dis</source>. <year>2006</year>;<volume>12</volume>: <fpage>624</fpage>&#x2013;<lpage>630</lpage>. doi:<pub-id pub-id-type="doi">10.3201/eid1204.050450</pub-id></mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Galav&#x00ED;z-Silva</surname> <given-names>L</given-names></string-name>, <string-name><surname>Molina-Garza</surname> <given-names>DP</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Santos</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Mercado-Hern&#x00E1;ndez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Galav&#x00ED;z</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Rosales-Encina</surname> <given-names>JL</given-names></string-name>, <etal>et al.</etal> <article-title>Update on seroprevalence of anti-<italic>Trypanosoma cruzi</italic> antibodies among blood donors in Northeast Mexico</article-title>. <source>Am J Trop Med Hyg</source>. <year>2009</year>;<volume>81</volume>: <fpage>404</fpage>&#x2013;<lpage>406</lpage>. doi:<pub-id pub-id-type="doi">81/3/404 [pii]</pub-id></mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Gamboa-Le&#x00F3;n</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ramirez-Gonzalez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Pacheco-Tucuch</surname> <given-names>FS</given-names></string-name>, <string-name><surname>O&#x2019;Shea</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rosecrans</surname> <given-names>K</given-names></string-name>, <string-name><surname>Pippitt</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Seroprevalence of <italic>Trypanosoma cruzi</italic> among mothers and children in rural Mayan communities and associated reproductive outcomes</article-title>. <source>Am J Trop Med Hyg</source>. <year>2014</year>;<volume>91</volume>: <fpage>348</fpage>&#x2013;<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.13-0527</pub-id></mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Gamboa-Le&#x00F3;n</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gonzalez-Ramirez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Padilla-Raygoza</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sosa-Estani</surname> <given-names>S</given-names></string-name>, <string-name><surname>Caamal-Kantun</surname> <given-names>A</given-names></string-name>, <string-name><surname>Buekens</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Do commercial serologic tests for <italic>Trypanosoma cruzi</italic> infection detect Mexican strains in women and newborns?</article-title> <source>J Parasitol</source>. <year>2011</year>;<volume>97</volume>: <fpage>338</fpage>&#x2013;<lpage>343</lpage>. doi:<pub-id pub-id-type="doi">10.1645/GE-2545.1</pub-id></mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Garc&#x00ED;a-Montalvo</surname> <given-names>B.</given-names></string-name> <article-title><italic>Trypanosoma cruzi</italic> antibodies in blood donors in Yucatan state, Mexico</article-title>. <source>Rev Med Inst Mex Seguro Soc</source>. <year>2011</year>;<volume>97</volume>: <fpage>338</fpage>&#x2013;<lpage>343</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Guzm&#x00E1;n-G&#x00F3;mez</surname> <given-names>D</given-names></string-name>, <string-name><surname>L&#x00F3;pez-Monteon</surname> <given-names>A</given-names></string-name>, <string-name><surname>De La Soledad Lagunes-Castro</surname> <given-names>M</given-names></string-name>, <string-name><surname>&#x00C1;lvarez-Mart&#x00ED;nez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez-Lutzon</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Dumonteil</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>Highly discordant serology against <italic>Trypanosoma cruzi</italic> in central Veracruz, Mexico: Role of the antigen used for diagnostic</article-title>. <source>Parasites and Vectors</source>. <year>2015</year>;<volume>8</volume>: <fpage>466</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13071-015-1072-2</pub-id></mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Hern&#x00E1;ndez-Romano</surname> <given-names>P</given-names></string-name>, <string-name><surname>C&#x00E1;mara-Contreras</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bravo-Sarmiento</surname> <given-names>E</given-names></string-name>, <string-name><surname>L&#x00F5;pez-Balderas</surname> <given-names>N.</given-names></string-name> <article-title>Prevalence of <italic>Trypanosoma cruzi</italic> antibodies in blood donors from Veracruz State, Mexico</article-title>. <source>Transfusion</source>. <year>2015</year>;<volume>55</volume>: <fpage>647</fpage>&#x2013;<lpage>656</lpage>. doi:<pub-id pub-id-type="doi">10.1111/trf.12860</pub-id></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Jim&#x00E9;nez Cardoso</surname> <given-names>E</given-names></string-name>, <string-name><surname>Campos Vald&#x00E9;z</surname> <given-names>G</given-names></string-name>, <string-name><surname>Cortes Campos</surname> <given-names>A</given-names></string-name>, <string-name><surname>de la Luz Sanchez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Riviera Mendoza</surname> <given-names>C</given-names></string-name>, <string-name><surname>Plascencia Hern&#x00E1;ndez</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Maternal fetal transmission of <italic>Trypanosoma cruzi</italic>: A problem of public health little studied in Mexico</article-title>. <source>Exp Parasitol</source>. <year>2012</year>;<volume>131</volume>: <fpage>425</fpage>&#x2013;<lpage>432</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.exppara.2012.05.013</pub-id></mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Jim&#x00E9;nez-Coello</surname> <given-names>M</given-names></string-name>, <string-name><surname>Guzm&#x00E1;n-Mar&#x00ED;n</surname> <given-names>E</given-names></string-name>, <string-name><surname>Ortega-Pacheco</surname> <given-names>A</given-names></string-name>, <string-name><surname>Acosta-Viana</surname> <given-names>KY</given-names></string-name>. <article-title>Serological survey of American trypanosomiasis in dogs and their owners from an urban area of Merida Yucatan, Mexico</article-title>. <source>Transbound Emerg Dis</source>. <year>2010</year>;<volume>57</volume>: <fpage>33</fpage>&#x2013;<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1865-1682.2010.01130.x</pub-id></mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Juarez-Tobias</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vaughan</surname> <given-names>G</given-names></string-name>, <string-name><surname>Torres-Montoya</surname> <given-names>A</given-names></string-name>, <string-name><surname>Escobar-Gutierrez</surname> <given-names>A.</given-names></string-name> <article-title>Short report: Seroprevalence of <italic>Trypanosoma cruzi</italic> among Teenek Amerindian residents of the Huasteca region in San Luis Potosi, Mexico</article-title>. <source>Am J Trop Med Hyg</source>. <year>2009</year>;<volume>81</volume>: <fpage>219</fpage>&#x2013;<lpage>222</lpage>. doi:<pub-id pub-id-type="doi">81/2/219 [pii]</pub-id></mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Kirchhoff</surname> <given-names>L V.</given-names></string-name>, <string-name><surname>Paredes</surname> <given-names>P</given-names></string-name>, <string-name><surname>LomeL&#x00ED;-Guerrero</surname> <given-names>A</given-names></string-name>, <string-name><surname>Paredes-Espinoza</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ron-Guerrero</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Delgado-Mej&#x00ED;a</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States</article-title>. <source>Transfusion</source>. <year>2006</year>;<volume>46</volume>: <fpage>298</fpage>&#x2013;<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1537-2995.2006.00715.x</pub-id></mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>L&#x00F3;pez-C&#x00E9;spedes</surname> <given-names>&#x00C1;</given-names></string-name>, <string-name><surname>Villagr&#x00E1;n</surname> <given-names>E</given-names></string-name>, <string-name><surname>Brice&#x00F1;o</surname> <given-names>&#x00C1;lvarez K</given-names></string-name>, <string-name><surname>De Diego</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez-Montiel</surname> <given-names>HL</given-names></string-name>, <string-name><surname>Salda&#x00F1;a</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title><italic>Trypanosoma cruzi</italic>: seroprevalence detection in suburban population of Santiago de Quer&#x00E9;taro (Mexico)</article-title>. <source>Sci World J</source>. <year>2012</year>;<volume>2012</volume>: <fpage>8</fpage>&#x2013;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1100/2012/914129</pub-id></mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Manne-Goehler</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ramsey</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Salgado</surname> <given-names>MO</given-names></string-name>, <string-name><surname>Wirtz</surname> <given-names>VJ</given-names></string-name>, <string-name><surname>Reich</surname> <given-names>MR</given-names></string-name>. <article-title>Increasing access to treatment for Chagas disease: the case of Morelos, Mexico</article-title>. <source>Am J Trop Med Hyg</source>. <year>2014</year>;<volume>91</volume>: <fpage>1125</fpage>&#x2013;<lpage>1127</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.14-0357</pub-id></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Mart&#x00ED;nez-Tovar</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Rebollar-T&#x00E9;llez</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Fern&#x00E1;ndez Salas</surname> <given-names>I.</given-names></string-name> <article-title>Seroprevalence of T. cruzi infection in blood donors and Chagas cardiomyopathy in patients from the coal mining region of Coahuila, Mexico</article-title>. <source>Rev Inst Med Trop Sao Paulo</source>. <year>2014</year>;<volume>56</volume>: <fpage>169</fpage>&#x2013;<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0036-46652014000200014</pub-id></mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Molina-Garza</surname> <given-names>ZJ</given-names></string-name>, <string-name><surname>Rosales-Encina</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Mercado-Hern&#x00E1;ndez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Molina-Garza</surname> <given-names>DP</given-names></string-name>, <string-name><surname>Gomez-Flores</surname> <given-names>R</given-names></string-name>, <string-name><surname>Galaviz-Silva</surname> <given-names>L.</given-names></string-name> <article-title>Association of <italic>Trypanosoma cruzi</italic> infection with risk factors and electrocardiographic abnormalities in northeast Mexico</article-title>. <source>BMC Infect Dis</source>. <year>2014</year>;<volume>14</volume>: <fpage>117</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2334-14-117</pub-id></mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Monteon</surname> <given-names>V</given-names></string-name>, <string-name><surname>Alducin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ramos-Ligonio</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lopez</surname> <given-names>R.</given-names></string-name> <article-title>High frequency of human blood in <italic>Triatoma dimidiata</italic> captured inside dwellings in a rural community in the Yucatan Peninsula, Mexico, but low antibody seroprevalence and electrocardiographic findings compatible with Chagas disease in humans</article-title>. <source>Am J Trop Med Hyg</source>. <year>2013</year>;<volume>88</volume>: <fpage>566</fpage>&#x2013;<lpage>571</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.12-0583</pub-id></mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Montes-Rinc&#x00F3;n</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Galaviz-Silva</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Bravo</surname> <given-names>FE</given-names></string-name>, <string-name><surname>Molina-Garza</surname> <given-names>ZJ</given-names></string-name>. <article-title><italic>Trypanosoma cruzi</italic> seroprevalence in pregnant women and screening by PCR and microhaematocrit in newborns from Guanajuato, Mexico</article-title>. <source>Acta Trop. Elsevier B.V</source>.; <year>2016</year>;<volume>164</volume>: <fpage>100</fpage>&#x2013;<lpage>106</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.actatropica.2016.08.029</pub-id></mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Newton-Sanchez</surname> <given-names>OA</given-names></string-name>, <string-name><surname>Espinoza-Gomez</surname> <given-names>F</given-names></string-name>, <string-name><surname>Melnikov</surname> <given-names>V</given-names></string-name>, <string-name><surname>Delgado-Enciso</surname> <given-names>I</given-names></string-name>, <string-name><surname>Rojas-Larios</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dumonteil</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>Seroprevalence of <italic>Trypanosoma cruzi</italic> (TC) and risk factors in Colima, Mexico</article-title>. <source>Gac Med Mex</source>. <year>2017</year>;<volume>153</volume>: <fpage>179</fpage>&#x2013;<lpage>184</lpage>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Novelo-Garza</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Ben&#x00ED;tez-Arvizu</surname> <given-names>G</given-names></string-name>, <string-name><surname>Pe&#x00F1;a-Ben&#x00ED;tez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Galv&#x00E1;n-Cervantes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Morales-Rojas</surname> <given-names>A.</given-names></string-name> <article-title>Detecci&#x00F3;n de <italic>Trypanosoma cruzi</italic> en donadores de sangre</article-title>. <source>Rev Medica del IMSS</source>. <year>2010</year>;<volume>48</volume>: <fpage>139</fpage>&#x2013;<lpage>144</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://search.ebscohost.com/login.aspx?direct=true&#x0026;db=a9h&#x0026;AN=82512272&#x0026;lang=es&#x0026;site=ehost-live">http://search.ebscohost.com/login.aspx?direct=true&#x0026;db=a9h&#x0026;AN=82512272&#x0026;lang=es&#x0026;site=ehost-live</ext-link></mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Olivera</surname> <given-names>Mar</given-names></string-name> A, <string-name><surname>Ortega</surname> <given-names>FG</given-names></string-name>, <string-name><surname>Vidal</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez-Becerril</surname> <given-names>N</given-names></string-name>, <string-name><surname>Galdamez</surname> <given-names>EP</given-names></string-name>, <string-name><surname>Concepci&#x00F3;n</surname> <given-names>GC</given-names></string-name>, <etal>et al.</etal> <article-title>Serological and parasitological screening of <italic>Trypanosoma cruzi</italic> infection in mothers and newborns living in two chagasic areas of Mexico</article-title>. <source>Arch Med Res</source>. <year>2006</year>;<volume>37</volume>: <fpage>774</fpage>&#x2013;<lpage>777</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arcmed.2006.02.006</pub-id></mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Portugal-Garc&#x00ED;a</surname> <given-names>C</given-names></string-name>, <string-name><surname>Garc&#x00ED;a-V&#x00E1;zquez</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Monte&#x00F3;n-Padilla</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ch&#x00E1;vez-L&#x00F3;pez</surname> <given-names>V</given-names></string-name>, <string-name><surname>Olamendi-Portugal</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ramos</surname> <given-names>C.</given-names></string-name> <article-title>Anticuerpos contra <italic>Trypanosoma cruzi</italic> en humanos y perros y presencia del par&#x00E1;sito en Meccus pallidipennis en la localidad de Puente Pantitl&#x00E1;n, Morelos, M&#x00E9;xico</article-title>. <source>Biomedica</source>. <year>2011</year>;<volume>22</volume>: <fpage>67</fpage>&#x2013;<lpage>75</lpage>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Ramos-Ligonio</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ram&#x00ED;rez-S&#x00E1;nchez</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Hern&#x00E1;ndez</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Rosales-Encina</surname> <given-names>JL</given-names></string-name>, <string-name><surname>L&#x00F3;pez-Monteon</surname> <given-names>A.</given-names></string-name> <article-title>Prevalencia de anticuerpos contra <italic>Trypanosoma cruzi</italic> en donadores de sangre del IMSS, Orizaba, Veracruz, M&#x00E9;xico</article-title>. <source>Salud Publica Mex</source>. <year>2006</year>;<volume>48</volume>: <fpage>13</fpage>&#x2013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0036-36342006000100004</pub-id></mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Ruiz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Salazar</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Rojas</surname> <given-names>G</given-names></string-name>, <string-name><surname>Guevara</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Torres</surname> <given-names>E</given-names></string-name>, <string-name><surname>Guti&#x00E9;rrez</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Seguimiento serol&#x00F3;gico de hijos de madres seropositivas a <italic>Trypanosoma cruzi</italic> en la jurisdicci&#x00F3;n sanitaria de Tuxpan, Veracruz, M&#x00E9;xico</article-title>. <source>Biom&#x00E9;dica</source>. <year>2011</year>;<volume>31</volume>: <fpage>23</fpage>&#x2013;<lpage>205</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Salazar</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Rojas</surname> <given-names>G</given-names></string-name>, <string-name><surname>Bucio</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cabrera</surname> <given-names>M</given-names></string-name>, <string-name><surname>Garc&#x00ED;a</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ruiz</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Seroprevalencia de anticuerpos contra <italic>Trypanosoma cruzi</italic> y su asociaci&#x00F3;n con factores de riesgo en menores de 18 a&#x00F1;os de Veracruz, M&#x00E9;xico</article-title>. <source>Rev Panam Salud P&#x00FA;blica</source>. <year>2007</year>;<volume>22</volume>: <fpage>75</fpage>&#x2013;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S1020-49892007000700001</pub-id></mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Salazar-Schettino</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Perera</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ruiz-Hernandez</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Bucio Torres</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Zamora-Gonzalez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Cabrera-Bravo</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Chagas disease as a cause of symptomatic chronic myocardopathy in mexican children</article-title>. <source>Pediatr Infect Dis J</source>. <year>2009</year>;<volume>28</volume>: <fpage>1011</fpage>&#x2013;<lpage>1013</lpage>. doi:<pub-id pub-id-type="doi">10.1097/INF.0b013e3181ad8425</pub-id></mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Salazar-Schettino</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Cabrera-Bravo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Vazquez-Antona</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zenteno</surname> <given-names>E</given-names></string-name>, <string-name><given-names>Alba-Alvarado M</given-names> <surname>De</surname></string-name>, <string-name><surname>Gutierrez</surname> <given-names>ET</given-names></string-name>, <etal>et al.</etal> <article-title>Chagas disease in Mexico: report of 14 cases of chagasic cardiomyopathy in children</article-title>. <source>Tohoku J Exp Med</source>. <year>2016</year>;<volume>240</volume>: <fpage>243</fpage>&#x2013;<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.1620/tjem.240.243</pub-id></mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>S&#x00E1;nchez-Guill&#x00E9;n</surname> <given-names>M</given-names></string-name> <string-name><surname>del</surname> <given-names>C</given-names></string-name>, <string-name><surname>L&#x00F3;pez-Colombo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ord&#x00F3;&#x00F1;ez-Toquero</surname> <given-names>G</given-names></string-name>, <string-name><surname>Gomez-Albino</surname> <given-names>I</given-names></string-name>, <string-name><surname>Ramos-Jimenez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Torres-Rasgado</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>Clinical forms of <italic>Trypanosoma cruzi</italic> infected individuals in the chronic phase of Chagas disease in Puebla, Mexico</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2006</year>;<volume>101</volume>: <fpage>733</fpage>&#x2013;<lpage>740</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0074-02762006000700005</pub-id></mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Villagr&#x00E1;n</surname> <given-names>ME</given-names></string-name>, <string-name><surname>S&#x00E1;nchez-Moreno</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mar&#x00ED;n</surname> <given-names>C</given-names></string-name>, <string-name><surname>Uribe</surname> <given-names>M</given-names></string-name>, <string-name><surname>de la Cruz</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>de Diego</surname> <given-names>JA</given-names></string-name>. <article-title>Seroprevalence to <italic>Trypanosoma cruzi</italic> in rural communities of the state of Quer&#x00E9;taro (Mexico). Statistical evaluation of tests. Clin Biochem</article-title>. <source>The Canadian Society of Clinical Chemists</source>; <year>2009</year>;<volume>42</volume>: <fpage>12</fpage>&#x2013;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2008.09.122</pub-id></mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Villagr&#x00E1;n-Herrera</surname> <given-names>ME</given-names></string-name>, <string-name><surname>S&#x00E1;nchez-Moreno</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rodr&#x00ED;guez-M&#x00E9;ndez</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Hern&#x00E1;ndez-Montiel</surname> <given-names>HL</given-names></string-name>, <string-name><surname>D&#x00E1;vila-Esquivel</surname> <given-names>F</given-names></string-name> <string-name><surname>de</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-P&#x00E9;rez</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Comparative serology techniques for the diagnosis of <italic>Trypanosoma cruzi</italic> infection in a rural population from the state of Quer&#x00E9;taro, Mexico</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2014</year>;<volume>109</volume>: <fpage>967</fpage>&#x2013;<lpage>972</lpage>. doi:<pub-id pub-id-type="doi">10.1590/0074-0276130413</pub-id></mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Eaton</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Rehle</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Jooste</surname> <given-names>S</given-names></string-name>, <string-name><surname>Nkambule</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Mahy</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates</article-title>. <source>AIDS</source>. <year>2014</year>;<volume>28</volume>: <fpage>S507</fpage>&#x2013;<lpage>S514</lpage>. doi:<pub-id pub-id-type="doi">10.1097/QAD.0000000000000412</pub-id></mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Carlier</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sosa-Estani</surname> <given-names>S</given-names></string-name>, <string-name><surname>Luquetti</surname> <given-names>AO</given-names></string-name>, <string-name><surname>Buekens</surname> <given-names>P.</given-names></string-name> <article-title>Congenital Chagas disease: An update</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2015</year>;<volume>110</volume>: <fpage>363</fpage>&#x2013;<lpage>368</lpage>. doi:<pub-id pub-id-type="doi">10.1590/0074-02760140405</pub-id></mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Moure</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Angheben</surname> <given-names>A</given-names></string-name>, <string-name><surname>Molina</surname> <given-names>I</given-names></string-name>, <string-name><surname>Gobbi</surname> <given-names>F</given-names></string-name>, <string-name><surname>Espasa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Anselmi</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Serodiscordance in chronic Chagas disease diagnosis: a real problem in non-endemic countries</article-title>. <source>Clin Microbiol Infect</source>. <year>2016</year>;<volume>22</volume>: <fpage>788</fpage>&#x2013;<lpage>792</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmi.2016.06.001</pub-id></mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="book"><collab>Organizaci&#x00F3;n Panamericana de la Salud and Organizaci&#x00F3;n Mundial de la Salud (OPS &#x0026; OMS)</collab>. <source>Estimaci&#x00F3;n cuantitativa de la enfermedad de Chagas en las Am&#x00E9;ricas. by</source> <person-group person-group-type="editor"><string-name><surname>Jean</surname>, <given-names>J</given-names></string-name> <string-name><surname>Roberto</surname>, <given-names>S.</given-names></string-name></person-group> <year>2006</year>;<publisher-loc>OPS: Montevideo, Uruguay</publisher-loc>. doi:<pub-id pub-id-type="doi">OPS/HDM/CD/425-06</pub-id></mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Manne</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Snively</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Ramsey</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Salgado</surname> <given-names>MO</given-names></string-name>, <string-name><surname>B&#x00E4;rnighausen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Reich</surname> <given-names>MR</given-names></string-name>. <article-title>Barriers to treatment access for Chagas disease in Mexico</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>;<volume>7</volume>. doi:<pub-id pub-id-type="doi">10.1371/journal.pntd.0002488</pub-id></mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Ballinas-Verdugo</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Mej&#x00ED;a-Dom&#x00ED;nguez</surname> <given-names>AM</given-names></string-name>, <string-name><surname>S&#x00E1;nchez-Guerrero</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Lerma</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mart&#x00ED;nez-Cruz</surname> <given-names>M</given-names></string-name>, <string-name><surname>&#x00C1;lvarez-Manilla-Toquero</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>The type of <italic>Trypanosoma cruzi</italic> strain (native or non-native) used as substrate for immunoassays influences the ability of screening asymptomatic blood donors</article-title>. <source>Rev Invest Clin</source>. <year>2016</year>;<volume>68</volume>: <fpage>286</fpage>&#x2013;<lpage>291</lpage>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Dumonteil</surname> <given-names>E</given-names></string-name>, <string-name><surname>Herrera</surname> <given-names>C.</given-names></string-name> <article-title>Ten years of Chagas disease research: looking back to achievements, looking ahead to challenges</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2017</year>;<volume>11</volume>: <fpage>e0005422</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pntd.0005422</pub-id></mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Rosenthal</surname> <given-names>J.</given-names></string-name> <article-title>Climate change and the geographic distribution of infectious diseases</article-title>. <source>Ecohealth</source>. <year>2009</year>;<volume>6</volume>: <fpage>489</fpage>&#x2013;<lpage>495</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10393-010-0314-1</pub-id></mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Buekens</surname> <given-names>P</given-names></string-name>, <string-name><surname>Almendares</surname> <given-names>O</given-names></string-name>, <string-name><surname>Carlier</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Dumonteil</surname> <given-names>E</given-names></string-name>, <string-name><surname>Eberhard</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gamboa-Leon</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Mother-to-child transmission of Chagas&#x2019; disease in North America: Why don&#x2019;t we do more?</article-title> <source>Matern Child Health J</source>. <year>2008</year>;<volume>12</volume>: <fpage>283</fpage>&#x2013;<lpage>286</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10995-007-0246-8</pub-id></mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Stillwaggon</surname> <given-names>E</given-names></string-name>, <string-name><surname>Perez-Zetune</surname> <given-names>V</given-names></string-name>, <string-name><surname>Bialek</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Montgomery</surname> <given-names>SP</given-names></string-name>. <article-title>Congenital chagas disease in the United States: cost savings through maternal screening</article-title>. <source>Am J Trop Med Hyg</source>. <year>2018</year>;<volume>98</volume>: <fpage>1733</fpage>&#x2013;<lpage>1742</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.17-0818</pub-id></mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Ramsey</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Townsend Peterson</surname> <given-names>A</given-names></string-name>, <string-name><surname>Carmona-Castro</surname> <given-names>O</given-names></string-name>, <string-name><surname>Moo-Llanes</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Nakazawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Butrick</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2015</year>;<volume>110</volume>: <fpage>339</fpage>&#x2013;<lpage>352</lpage>. doi:<pub-id pub-id-type="doi">10.1590/0074-02760140404</pub-id></mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Gourbi&#x00E8;re</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dorn</surname> <given-names>P</given-names></string-name>, <string-name><surname>Tripet</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dumonteil</surname> <given-names>E.</given-names></string-name> <article-title>Genetics and evolution of triatomines: From phylogeny to vector control</article-title>. <source>Heredity (Edinb)</source>. <year>2012</year>;<volume>108</volume>: <fpage>190</fpage>&#x2013;<lpage>202</lpage>. doi:<pub-id pub-id-type="doi">10.1038/hdy.2011.71</pub-id></mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Waleckx</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gourbi&#x00E8;re</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dumonteil</surname> <given-names>E.</given-names></string-name> <article-title>Intrusive versus domiciliated triatomines and the challenge of adapting vector control practices against chagas disease</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2015</year>;<volume>110</volume>: <fpage>324</fpage>&#x2013;<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1590/0074-02760140409</pub-id></mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Hern&#x00E1;ndez-Becerril</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mej&#x00ED;a</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Ballinas-Verdugo</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Garza-Murillo</surname> <given-names>V</given-names></string-name>, <string-name><surname>Manilla-Toquero</surname> <given-names>E</given-names></string-name>, <string-name><surname>L&#x00F3;pez</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Blood transfusion and iatrogenic risks in Mexico city. Anti-<italic>Trypanosoma cruzi</italic> seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2005</year>;<volume>100</volume>: <fpage>111</fpage>&#x2013;<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0074-02762005000200002</pub-id></mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Guzm&#x00E1;n</surname> <given-names>Bracho</given-names></string-name>, <string-name><surname>Carmen Garc&#x00ED;a</surname> <given-names>Garc&#x00ED;a</given-names></string-name>, <string-name><surname>Lourdes Floriani</surname> <given-names>Verdugo</given-names></string-name>, <string-name><surname>Jorge Guerrero</surname> <given-names>Mart&#x00ED;nez</given-names></string-name>, <string-name><surname>Sandra Torres</surname> <given-names>Cosme</given-names></string-name>, <string-name><surname>Mario Ram&#x00ED;rez</surname> <given-names>Melgar</given-names></string-name>, <string-name><surname>Carmen Velasco Castrej&#x00F3;n</surname> <given-names>O.</given-names></string-name> <article-title>Riesgo de transmisi&#x00F3;n de <italic>Trypanosoma cruzi</italic> por transfusi&#x00F3;n de sangre en M&#x00E9;xico</article-title>. <source>Rev Panam Salud Publica</source>. <year>1998</year>;<volume>4</volume>: <fpage>94</fpage>&#x2013;<lpage>99</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S1020-49891998000800004">http://dx.doi.org/10.1590/S1020-49891998000800004</ext-link>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Willoquet</surname> <given-names>JMR</given-names></string-name>. <article-title>Chagas disease transmission in Mexico: a case for translational research, while waiting to take disease burden seriously</article-title>. <source>Salud Publica Mex</source>. <year>2007</year>;<volume>49</volume>: <fpage>e291</fpage>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Schmunis</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Cruz</surname> <given-names>JR</given-names></string-name>. <article-title>Safety of the blood supply in Latin America</article-title>. <source>Clin Microbiol Rev</source>. <year>2005</year>;<volume>18</volume>: <fpage>12</fpage>&#x2013;<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CMR.18.1.12-29.2005</pub-id></mixed-citation></ref>
</ref-list>
<sec id="s7">
<title>Supporting information</title>
<p>S1: PRISMA checklist</p>
<p>S2: PRISMA flow diagram</p>
</sec>
</back>
</article>